Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway

被引:112
作者
Ide, Takao [1 ]
Kitajima, Yoshihiko [1 ]
Miyoshi, Atsushi [1 ]
Ohtsuka, Takao [1 ]
Mitsuno, Mayumi [1 ]
Ohtaka, Kazuma [1 ]
Koga, Yasuo [1 ]
Miyazaki, Kohji [1 ]
机构
[1] Saga Univ, Fac Med, Dept Surg, Saga 8498501, Japan
关键词
hypoxia; tumor-stromal interaction; pancreatic cancer; hepatocyte growth factor; c-Met;
D O I
10.1002/ijc.22178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The hypoxic environment in tumor is reported to play an important role in pancreatic cancer progression. The interaction between stromal and cancer cells also contributes to the malignant behavior of pancreatic cancer. In the present study, we investigated whether hypoxic stimulation affects stromal as well as pancreatic cancer cells. Our findings demonstrated that hypoxia remarkably elevated the HIF-1 alpha expression in both pancreatic cancer (PK8) and fibroblast cells (MRC5). Hypoxic stimulation accelerated the invasive activity of PK8 cells, and invasiveness was thus further accelerated when the hypoxic PK8 cells were cultured with conditioned medium prepared from hypoxic MRC5 cells (hypoxic conditioned medium). MMP-2, MMP-7, MT1-MMP and c-Met expressions were increased in PK8 cells under hypoxia. Hypoxic stimulation also increased the hepatocyte growth factor (HGF) secretion from MRC5 cells, which led to an elevation of c-Met phosphorylation in PK8 cells. Conversely, the elevated cancer invasion, MMP activity and c-Met phosphorylation of PK8 cells were reduced by the removal of HGF from hypoxic conditioned medium. In immunohistochemical study, the HIF-1 alpha expression was observed in surrounding stromal as well as pancreatic cancer cells, thus indicating hypoxia exists in both of cancer and stromal cells. Moreover, the stromal HGF expression was found to significantly correlate with not only the stromal HIF-1a expression but also the c-Met expression in cancer cells. These results indicate that the hypoxic environment within stromal as well as cancer cells activates the HGF/c-Met system, thereby contributing to the aggressive invasive features of pancreatic cancer. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:2750 / 2759
页数:10
相关论文
共 48 条
[1]   Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia [J].
Berger, AP ;
Kofler, K ;
Bektic, J ;
Rogatsch, H ;
Steiner, H ;
Bartsch, G ;
Klocker, H .
PROSTATE, 2003, 57 (01) :57-65
[2]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[3]   TREATMENT AND SURVIVAL IN 13560 PATIENTS WITH PANCREATIC-CANCER, AND INCIDENCE OF THE DISEASE, IN THE WEST MIDLANDS - AN EPIDEMIOLOGIC-STUDY [J].
BRAMHALL, SR ;
ALLUM, WH ;
JONES, AG ;
ALLWOOD, A ;
CUMMINS, C ;
NEOPTOLEMOS, JP .
BRITISH JOURNAL OF SURGERY, 1995, 82 (01) :111-115
[4]   FIBROBLAST-MEDIATED ACCELERATION OF HUMAN EPITHELIAL TUMOR-GROWTH INVIVO [J].
CAMPS, JL ;
CHANG, SM ;
HSU, TC ;
FREEMAN, MR ;
HONG, SJ ;
ZHAU, HE ;
VONESCHENBACH, AC ;
CHUNG, LWK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :75-79
[5]   Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer:: Retrospective study in a series of 745 patients [J].
Dales, JP ;
Garcia, S ;
Meunier-Carpentier, S ;
Andrac-Meyer, L ;
Haddad, O ;
Lavaut, MN ;
Allasia, C ;
Bonnier, P ;
Charpin, C .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) :734-739
[6]   Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor [J].
Date, K ;
Matsumoto, K ;
Kuba, K ;
Shimura, H ;
Tanaka, M ;
Nakamura, T .
ONCOGENE, 1998, 17 (23) :3045-3054
[7]   AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma [J].
DiMagno, EP ;
Reber, HA ;
Tempero, MA .
GASTROENTEROLOGY, 1999, 117 (06) :1464-1484
[8]  
Durand RE, 1998, CANCER RES, V58, P3547
[9]  
DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
[10]  
Giatromanolaki A, 2001, ANTICANCER RES, V21, P4317